BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20261025T210210Z - 24046@eupv304
DTSTART;TZID=Europe/Brussels:20240425T113000
DTEND;TZID=Europe/Brussels:20240425T123000
CREATED:20261025T210210Z
DESCRIPTION:<a href="https://www.analis.com/event/webinar-the-analysis-of-o
 ligonucleotides-rna-dna-by-capillary-electrophoresis-in-cell-gene-therapy-
 vaccines-41/register">Webinar - The Analysis of Oligonucleotides\, RNA & D
 NA by Capillary Electrophoresis in Cell & Gene Therapy & Vaccines</a>\nFRE
 E REGISTRATION 25th April 2024 from 11:30 - Online meeting Steve Lock\, th
 e senior marketing & market development manager biopharma and capillary el
 ectrophoresis from Sciex will present an update of what CE is capable of i
 n the field of cell and gene therapy (CGT) as well as vaccine development.
  Analis has been distributing Sciex CE products since 2014. As both Belgiu
 m and Luxembourg are very active in the field of CGT and vaccine developme
 nt\, we believe below subject will be of great interest to our current CE 
 user base\, but also to anyone interested in what Sciex CE systems allow y
 ou to do for … The Analysis of Oligonucleotides\, RNA & DNA by Capillary
  Electrophoresis in Cell & Gene Therapy & Vaccines Below abstract summariz
 es Steve’s talk: The area of cell and gene therapy (CGT) research has ra
 pidly increased in the last few years\, especially after the successful de
 velopment of mRNA and viral vaccines to treat COVID. Capillary electrophor
 esis (CE)\, since its early days\, has been used for profiling RNA and DNA
  samples and is now seen as a useful tool for characterizing this class of
  drugs. In this online seminar you will find out how CE can be used to con
 trol the purity of plasmids used in the manufacture of vaccines and CGT pr
 oducts. Listeners will also discover how methods can be adapted to profile
  both small oligonucleotides to larger mRNA molecules. Finally\, you will 
 discover how CE has been developed for viral vector ssDNA profiling and to
 gether with viral protein analysis has enabled scientists to calculate emp
 ty vs full ratio for their viral vectors. Don't miss this opportunity & le
 arn more on: • How to analyze vaccines and cell and gene therapy product
 s such as: o Plasmids and mRNA purity … and o Viral vectors\, empty vs f
 ull ratios … • How to get results faster with Sciex’ new high-throug
 hput solutions. JOIN US Be sure to register for this one-hour [...]
DTSTAMP:20261025T210210Z
LOCATION:ONLINE MEETING
SUMMARY:Webinar - The Analysis of Oligonucleotides\, RNA & DNA by Capillary
  Electrophoresis in Cell & Gene Therapy & Vaccines
X-ALT-DESC;FMTTYPE=text/html:<a href="https://www.analis.com/event/webinar-
 the-analysis-of-oligonucleotides-rna-dna-by-capillary-electrophoresis-in-c
 ell-gene-therapy-vaccines-41/register">Webinar - The Analysis of Oligonucl
 eotides\, RNA & DNA by Capillary Electrophoresis in Cell & Gene Therapy & 
 Vaccines</a>\nFREE REGISTRATION 25th April 2024 from 11:30 - Online meetin
 g Steve Lock\, the senior marketing & market development manager biopharma
  and capillary electrophoresis from Sciex will present an update of what C
 E is capable of in the field of cell and gene therapy (CGT) as well as vac
 cine development. Analis has been distributing Sciex CE products since 201
 4. As both Belgium and Luxembourg are very active in the field of CGT and 
 vaccine development\, we believe below subject will be of great interest t
 o our current CE user base\, but also to anyone interested in what Sciex C
 E systems allow you to do for … The Analysis of Oligonucleotides\, RNA &
  DNA by Capillary Electrophoresis in Cell & Gene Therapy & Vaccines Below 
 abstract summarizes Steve’s talk: The area of cell and gene therapy (CGT
 ) research has rapidly increased in the last few years\, especially after 
 the successful development of mRNA and viral vaccines to treat COVID. Capi
 llary electrophoresis (CE)\, since its early days\, has been used for prof
 iling RNA and DNA samples and is now seen as a useful tool for characteriz
 ing this class of drugs. In this online seminar you will find out how CE c
 an be used to control the purity of plasmids used in the manufacture of va
 ccines and CGT products. Listeners will also discover how methods can be a
 dapted to profile both small oligonucleotides to larger mRNA molecules. Fi
 nally\, you will discover how CE has been developed for viral vector ssDNA
  profiling and together with viral protein analysis has enabled scientists
  to calculate empty vs full ratio for their viral vectors. Don't miss this
  opportunity & learn more on: • How to analyze vaccines and cell and gen
 e therapy products such as: o Plasmids and mRNA purity … and o Viral vec
 tors\, empty vs full ratios … • How to get results faster with Sciex
 ’ new high-throughput solutions. JOIN US Be sure to register for this on
 e-hour [...]
END:VEVENT
END:VCALENDAR
